OCTREOTIDE ACETATE

OCTREOTIDE ACETATE was reported 30706 times

OCTREOTIDE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 5-HYDROXYINDOLACETIC ACID INCREASED 44 0.6769
1 GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE 75 0.6757
2 CARCINOID CRISIS 152 0.6726
3 5-HYDROXYINDOLACETIC ACID IN URINE INCREASED 36 0.6545
4 BLOOD GROWTH HORMONE INCREASED 310 0.5556
5 CARCINOID HEART DISEASE 45 0.4945
6 METASTATIC CARCINOID TUMOUR 46 0.4423
7 BLOOD MERCURY ABNORMAL 41 0.4184
8 BLOOD CHROMOGRANIN A INCREASED 185 0.4031
9 CARCINOID TUMOUR 276 0.3710
10 CARCINOID SYNDROME 128 0.3536
11 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 83 0.3473
12 CARCINOID TUMOUR OF THE SMALL BOWEL 31 0.2981
13 NEUROENDOCRINE TUMOUR 412 0.2908
14 BLOOD GROWTH HORMONE ABNORMAL 34 0.2787
15 PANCREATIC NEUROENDOCRINE TUMOUR 178 0.2777
16 SERUM SEROTONIN INCREASED 81 0.2282
17 INSULIN-LIKE GROWTH FACTOR INCREASED 293 0.2053
18 ACROMEGALY 62 0.1956
19 INSULIN-LIKE GROWTH FACTOR DECREASED 89 0.1682
20 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 39 0.1612
21 NEUROENDOCRINE CARCINOMA METASTATIC 39 0.1585
22 BLOOD GROWTH HORMONE DECREASED 32 0.1584
23 BODY TEMPERATURE DECREASED 1461 0.1483
24 BLOOD PRESSURE SYSTOLIC INCREASED 2397 0.1228
25 BLOOD PRESSURE DIASTOLIC DECREASED 884 0.1196
26 METASTASES TO PANCREAS 52 0.1174
27 ANGINA BULLOSA HAEMORRHAGICA 26 0.1121
28 HEPATIC NEOPLASM 327 0.1001
29 NEEDLE ISSUE 2800 0.0961
30 METASTASES TO OVARY 27 0.0846
31 PITUITARY TUMOUR 121 0.0811
32 BLOOD PRESSURE DIASTOLIC INCREASED 366 0.0792
33 NEUROENDOCRINE CARCINOMA 52 0.0751
34 INTESTINAL METASTASIS 27 0.0744
35 HEPATIC LESION 316 0.0730
36 METASTASES TO ABDOMINAL CAVITY 35 0.0711
37 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 26 0.0665
38 METASTASES TO PELVIS 40 0.0633
39 SENSITISATION 48 0.0632
40 SECOND PRIMARY MALIGNANCY 513 0.0616
41 SCIATIC NERVE INJURY 49 0.0590
42 WHITE COAT HYPERTENSION 28 0.0517
43 BITE 37 0.0512
44 ADENOMA BENIGN 44 0.0512
45 GASTROINTESTINAL NEOPLASM 44 0.0508
46 METASTASES TO LIVER 828 0.0471
47 SHORT-BOWEL SYNDROME 30 0.0461
48 TUMOUR PAIN 59 0.0448
49 ABDOMINAL NEOPLASM 38 0.0426
50 VULVAL DISORDER 28 0.0424
51 VITAL FUNCTIONS ABNORMAL 36 0.0421
52 HEPATIC MASS 80 0.0415
53 GINGIVAL ABSCESS 31 0.0411
54 RECTAL POLYP 40 0.0405
55 EXCESSIVE CERUMEN PRODUCTION 25 0.0403
56 MUSCLE SWELLING 36 0.0391
57 PANCREATIC NEOPLASM 46 0.0372
58 BILIARY OBSTRUCTION 48 0.0370
59 SYRINGE ISSUE 641 0.0366
60 BLOOD PRESSURE SYSTOLIC DECREASED 166 0.0365
61 CORTISOL DECREASED 41 0.0359
62 HEPATIC PAIN 153 0.0358
63 PITUITARY TUMOUR BENIGN 58 0.0355
64 NEOPLASM 403 0.0350
65 TERMINAL STATE 231 0.0345
66 BILE DUCT OBSTRUCTION 62 0.0326
67 SPINAL CORD NEOPLASM 28 0.0321
68 HEART RATE DECREASED 1128 0.0321
69 SKIN SENSITISATION 33 0.0319
70 HYPOTHALAMO-PITUITARY DISORDER 46 0.0316
71 FAECES PALE 70 0.0314
72 FACIAL ASYMMETRY 30 0.0314
73 ONCOLOGIC COMPLICATION 30 0.0310
74 METASTASES TO SPINE 100 0.0297
75 HORMONE LEVEL ABNORMAL 143 0.0293
76 LOW DENSITY LIPOPROTEIN DECREASED 41 0.0289
77 PRODUCT DEPOSIT 45 0.0289
78 NASAL DISCHARGE DISCOLOURATION 39 0.0283
79 POLYP 184 0.0281
80 BONE NEOPLASM 30 0.0278
81 METASTASIS 196 0.0274
82 STEATORRHOEA 72 0.0269
83 NECROTISING COLITIS 34 0.0268
84 RADIOTHERAPY 51 0.0266
85 LABYRINTHITIS 65 0.0257
86 STOMA COMPLICATION 26 0.0256
87 LIVER ABSCESS 83 0.0256
88 GASTROINTESTINAL STOMA COMPLICATION 40 0.0254
89 INJECTION SITE MASS 919 0.0248
90 CHANGE OF BOWEL HABIT 51 0.0248
91 ABDOMINAL MASS 66 0.0246
92 INJECTION SITE OEDEMA 42 0.0244
93 MALIGNANT NEOPLASM PROGRESSION 2501 0.0244
94 PAROTITIS 28 0.0241
95 BOWEL MOVEMENT IRREGULARITY 184 0.0240
96 RECURRENT CANCER 96 0.0235
97 BILIARY COLIC 68 0.0234
98 MASS 326 0.0233
99 CHOLELITHIASIS 717 0.0218
100 INJECTION SITE HYPERSENSITIVITY 68 0.0217
101 INGROWING NAIL 51 0.0216
102 YELLOW SKIN 100 0.0213
103 CONCOMITANT DISEASE AGGRAVATED 131 0.0212
104 CACHEXIA 108 0.0210
105 RENAL NEOPLASM 43 0.0202
106 NECK MASS 56 0.0198
107 COCCYDYNIA 29 0.0197
108 BLOOD PRESSURE INCREASED 2989 0.0195
109 HEART VALVE INCOMPETENCE 56 0.0195
110 RENAL MASS 40 0.0194
111 PANCREATIC DISORDER 95 0.0193
112 INJECTION SITE DISCOMFORT 200 0.0190
113 METASTASES TO PERITONEUM 48 0.0190
114 FAECES SOFT 138 0.0190
115 CONCOMITANT DISEASE PROGRESSION 36 0.0184
116 SMALL INTESTINE CARCINOMA 41 0.0184
117 CHEST INJURY 38 0.0183
118 BILE DUCT STONE 58 0.0182
119 RESPIRATORY RATE INCREASED 160 0.0180
120 CANCER PAIN 46 0.0180
121 CEREBROSPINAL FLUID LEAKAGE 33 0.0178
122 INJECTION SITE SCAR 50 0.0175
123 PULSE ABNORMAL 42 0.0174
124 GASTROINTESTINAL WALL THICKENING 26 0.0174
125 NEOPLASM PROGRESSION 604 0.0174
126 INTRA-ABDOMINAL FLUID COLLECTION 31 0.0173
127 BLOOD MAGNESIUM DECREASED 146 0.0169
128 INFREQUENT BOWEL MOVEMENTS 42 0.0168
129 INDURATION 30 0.0168
130 THYROID NEOPLASM 46 0.0167
131 METASTASES TO BONE 272 0.0166
132 EARLY SATIETY 32 0.0164
133 GROIN PAIN 143 0.0163
134 CHOLECYSTITIS INFECTIVE 44 0.0158
135 ABDOMINAL ADHESIONS 50 0.0158
136 FLATULENCE 893 0.0157
137 CARDIAC VALVE DISEASE 90 0.0157
138 EATING DISORDER 335 0.0157
139 INTESTINAL OBSTRUCTION 592 0.0157
140 THYROID MASS 60 0.0156
141 ABNORMAL FAECES 127 0.0155
142 ABDOMINAL RIGIDITY 42 0.0155
143 URINE ABNORMALITY 70 0.0154
144 BLOOD IRON DECREASED 182 0.0153
145 RALES 89 0.0153
146 BREAST CYST 27 0.0152
147 BRAIN NEOPLASM 140 0.0152
148 METASTASES TO LYMPH NODES 101 0.0149
149 BLOOD CHOLESTEROL ABNORMAL 69 0.0149
150 PROCTALGIA 96 0.0149
151 METASTASES TO LUNG 172 0.0149
152 FAECES DISCOLOURED 316 0.0146
153 BREAST MASS 95 0.0141
154 FAECES HARD 55 0.0141
155 FLANK PAIN 128 0.0136
156 ADRENAL DISORDER 26 0.0135
157 POSTOPERATIVE WOUND INFECTION 91 0.0135
158 MUSCULOSKELETAL CHEST PAIN 208 0.0134
159 EYE CONTUSION 28 0.0132
160 PROSTATOMEGALY 52 0.0132
161 VITAMIN B12 DECREASED 38 0.0132
162 HYPERTONIC BLADDER 38 0.0131
163 LUNG NEOPLASM 56 0.0131
164 CREPITATIONS 39 0.0131
165 PRODUCT TEMPERATURE EXCURSION ISSUE 67 0.0130
166 BLOOD GLUCOSE FLUCTUATION 141 0.0129
167 BLOOD PARATHYROID HORMONE INCREASED 37 0.0127
168 BONE CANCER 55 0.0126
169 BLOOD PRESSURE DECREASED 819 0.0123
170 URINE ODOUR ABNORMAL 72 0.0122
171 BLOOD CHLORIDE DECREASED 31 0.0120
172 TUMOUR MARKER INCREASED 56 0.0117
173 HEART RATE IRREGULAR 259 0.0115
174 GASTROINTESTINAL MOTILITY DISORDER 61 0.0114
175 SMALL INTESTINAL OBSTRUCTION 140 0.0114
176 HEPATOMEGALY 111 0.0113
177 FRUSTRATION TOLERANCE DECREASED 91 0.0113
178 BLOOD POTASSIUM ABNORMAL 30 0.0112
179 INJECTION SITE INFLAMMATION 56 0.0112
180 BACTERIAL TEST POSITIVE 25 0.0112
181 RENAL CYST 89 0.0112
182 LIPOMA 29 0.0112
183 INJECTION SITE INDURATION 145 0.0112
184 GLUCOSE TOLERANCE IMPAIRED 66 0.0111
185 FREQUENT BOWEL MOVEMENTS 300 0.0111
186 HYPOGLYCAEMIA 537 0.0111
187 ABDOMINAL DISTENSION 1150 0.0110
188 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 779 0.0109
189 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1959 0.0109
190 BONE LESION 39 0.0108
191 GASTROINTESTINAL OBSTRUCTION 26 0.0108
192 ASCITES 317 0.0108
193 BODY TEMPERATURE INCREASED 220 0.0108
194 PSYCHIATRIC SYMPTOM 79 0.0107
195 SCIATICA 170 0.0107
196 ABDOMINAL PAIN 2480 0.0106
197 THYROID DISORDER 163 0.0106
198 DEFAECATION URGENCY 74 0.0106
199 FOOD INTOLERANCE 38 0.0104
200 MUSCULOSKELETAL DISCOMFORT 177 0.0103
201 MOVEMENT DISORDER 330 0.0103
202 GALLBLADDER DISORDER 182 0.0102
203 ABDOMINAL ABSCESS 45 0.0102
204 ABDOMINAL INFECTION 26 0.0102
205 FUNCTIONAL GASTROINTESTINAL DISORDER 35 0.0101
206 LIMB DISCOMFORT 313 0.0101
207 ABDOMINAL HERNIA 46 0.0101
208 URINE ANALYSIS ABNORMAL 30 0.0100
209 MUSCULOSKELETAL PAIN 525 0.0100
210 SPUTUM DISCOLOURED 95 0.0100
211 HEPATIC CYST 34 0.0100
212 VARICES OESOPHAGEAL 30 0.0099
213 ABDOMINAL PAIN LOWER 250 0.0099
214 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 26 0.0098
215 BLOOD SODIUM INCREASED 26 0.0096
216 POLYDIPSIA 38 0.0096
217 BLOOD POTASSIUM DECREASED 289 0.0096
218 BLOOD THYROID STIMULATING HORMONE DECREASED 43 0.0095
219 NEOPLASM RECURRENCE 32 0.0094
220 NEPHROLITHIASIS 431 0.0094
221 INGUINAL HERNIA 57 0.0094
222 GOUT 168 0.0094
223 FLUSHING 950 0.0093
224 SPINAL PAIN 109 0.0093
225 PRODUCTIVE COUGH 442 0.0092
226 MUSCLE STRAIN 80 0.0092
227 HAEMORRHOIDS 180 0.0092
228 SYNOVIAL CYST 42 0.0091
229 HYPOKINESIA 132 0.0091
230 BLOOD PRESSURE FLUCTUATION 218 0.0091
231 SLEEP APNOEA SYNDROME 173 0.0091
232 PALLOR 245 0.0090
233 BREAST PAIN 96 0.0090
234 DIABETES MELLITUS 684 0.0090
235 THROMBOPHLEBITIS SUPERFICIAL 27 0.0089
236 INJECTION SITE INFECTION 29 0.0088
237 MUSCLE CONTRACTIONS INVOLUNTARY 31 0.0088
238 TENDERNESS 91 0.0087
239 FACE INJURY 33 0.0087
240 ABDOMINAL TENDERNESS 43 0.0087
241 BLOOD URINE PRESENT 164 0.0086
242 LIGAMENT SPRAIN 85 0.0086
243 CYST 105 0.0085
244 PORTAL HYPERTENSION 26 0.0084
245 MALABSORPTION 44 0.0084
246 BLOOD GLUCOSE ABNORMAL 155 0.0084
247 FURUNCLE 66 0.0083
248 BLOOD TEST ABNORMAL 117 0.0083
249 PULMONARY MASS 124 0.0083
250 EXOSTOSIS 76 0.0083
251 ANAL INCONTINENCE 74 0.0082
252 WEIGHT DECREASED 2289 0.0082
253 BLOOD CALCIUM DECREASED 92 0.0082
254 HYPERGLYCAEMIA 298 0.0082
255 TOOTH ABSCESS 83 0.0081
256 BACK INJURY 88 0.0081
257 DUODENAL ULCER 57 0.0081
258 MALNUTRITION 90 0.0080
259 LARGE INTESTINE POLYP 55 0.0079
260 PERIPHERAL COLDNESS 109 0.0079
261 ELECTROLYTE IMBALANCE 92 0.0079
262 CHOLANGITIS 49 0.0079
263 UNDERDOSE 573 0.0078
264 ARTERIOSCLEROSIS CORONARY ARTERY 52 0.0078
265 FEELING COLD 218 0.0078
266 RENAL PAIN 83 0.0078
267 OBSTRUCTION 31 0.0078
268 BURSITIS 94 0.0077
269 DIZZINESS POSTURAL 75 0.0077
270 ARTHROPOD BITE 57 0.0077
271 WOUND SECRETION 30 0.0077
272 DECREASED IMMUNE RESPONSIVENESS 75 0.0076
273 BLOOD GLUCOSE DECREASED 358 0.0074
274 SKIN ABRASION 35 0.0074
275 CYSTITIS 235 0.0074
276 CONTUSION 710 0.0074
277 GENERAL PHYSICAL HEALTH DETERIORATION 850 0.0073
278 FEEDING DISORDER 149 0.0073
279 SPINAL OSTEOARTHRITIS 64 0.0073
280 POST PROCEDURAL INFECTION 59 0.0072
281 NERVOUSNESS 378 0.0072
282 INJECTION SITE PAIN 2209 0.0072
283 JOINT INJURY 153 0.0072
284 RIB FRACTURE 147 0.0071
285 PRODUCT SUPPLY ISSUE 51 0.0071
286 HERNIA 138 0.0071
287 VITAMIN D DECREASED 61 0.0071
288 DIARRHOEA 4568 0.0071
289 TENSION 43 0.0071
290 OSTEOARTHRITIS 299 0.0070
291 WOUND 197 0.0070
292 PROTEIN URINE PRESENT 35 0.0070
293 HELICOBACTER INFECTION 72 0.0070
294 BLOOD PROLACTIN INCREASED 33 0.0070
295 THYROID FUNCTION TEST ABNORMAL 29 0.0070
296 PIGMENTATION DISORDER 43 0.0070
297 SCAR 119 0.0069
298 PRODUCT LEAKAGE 39 0.0069
299 HIP FRACTURE 223 0.0069
300 MALAISE 3029 0.0069
301 GOITRE 28 0.0068
302 PHLEBITIS 35 0.0068
303 GASTROINTESTINAL PAIN 75 0.0068
304 HAEMATOCRIT DECREASED 135 0.0068
305 CORONAVIRUS INFECTION 45 0.0068
306 TRICUSPID VALVE INCOMPETENCE 54 0.0068
307 DYSURIA 250 0.0068
308 ANORECTAL DISCOMFORT 36 0.0068
309 DEVICE OCCLUSION 95 0.0067
310 BLADDER DISORDER 67 0.0067
311 HAEMOGLOBIN DECREASED 690 0.0067
312 POLYURIA 55 0.0067
313 OVERWEIGHT 36 0.0067
314 NODULE 87 0.0067
315 HEART RATE INCREASED 659 0.0066
316 CHOLECYSTITIS 79 0.0066
317 FACIAL PARALYSIS 56 0.0066
318 BACK PAIN 1526 0.0066
319 FOOD POISONING 35 0.0065
320 SKIN WARM 38 0.0065
321 ENDOMETRIOSIS 31 0.0065
322 PERIPHERAL SWELLING 995 0.0065
323 BODY HEIGHT DECREASED 69 0.0064
324 EPIGASTRIC DISCOMFORT 25 0.0064
325 MUSCLE FATIGUE 27 0.0064
326 BONE DISORDER 116 0.0064
327 ARTERIAL OCCLUSIVE DISEASE 50 0.0064
328 DISCOMFORT 388 0.0064
329 RHINORRHOEA 410 0.0063
330 JAUNDICE 170 0.0063
331 BONE PAIN 370 0.0063
332 HYPERVOLAEMIA 31 0.0063
333 KIDNEY INFECTION 123 0.0063
334 LOWER RESPIRATORY TRACT INFECTION 285 0.0063
335 LIMB INJURY 170 0.0063
336 INFLUENZA 697 0.0062
337 EAR DISCOMFORT 64 0.0062
338 VARICOSE VEIN 32 0.0062
339 ABDOMINAL PAIN UPPER 1274 0.0062
340 INJECTION SITE HAEMORRHAGE 493 0.0062
341 HOT FLUSH 465 0.0062
342 ERYSIPELAS 31 0.0062
343 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 105 0.0061
344 EAR DISORDER 28 0.0061
345 ASTHENIA 2294 0.0061
346 NOCTURIA 74 0.0061
347 GASTROINTESTINAL SOUNDS ABNORMAL 30 0.0060
348 SCAB 69 0.0060
349 HEAD DISCOMFORT 107 0.0060
350 DECREASED APPETITE 1398 0.0060
351 DYSSTASIA 175 0.0060
352 SCREAMING 38 0.0060
353 NASOPHARYNGITIS 1098 0.0060
354 SKIN ATROPHY 34 0.0059
355 OEDEMA PERIPHERAL 719 0.0059
356 GENERAL PHYSICAL CONDITION ABNORMAL 40 0.0059
357 SYNCOPE 588 0.0059
358 RED BLOOD CELL COUNT DECREASED 168 0.0059
359 AORTIC VALVE INCOMPETENCE 25 0.0059
360 SLUGGISHNESS 59 0.0058
361 ENTERITIS 37 0.0058
362 FOOT DEFORMITY 64 0.0058
363 URINE OUTPUT DECREASED 50 0.0057
364 DEPRESSED MOOD 302 0.0057
365 OVARIAN CYST 57 0.0057
366 ECCHYMOSIS 39 0.0057
367 HEAD INJURY 180 0.0057
368 NIGHT SWEATS 183 0.0057
369 BREATH SOUNDS ABNORMAL 28 0.0057
370 ONYCHOCLASIS 39 0.0057
371 DEHYDRATION 752 0.0056
372 GAIT DISTURBANCE 1074 0.0056
373 SKIN NECROSIS 29 0.0056
374 SHOCK HAEMORRHAGIC 45 0.0055
375 INTESTINAL PERFORATION 62 0.0055
376 BLOOD SODIUM DECREASED 104 0.0055
377 SCOLIOSIS 34 0.0055
378 BRADYCARDIA 291 0.0055
379 FALL 1826 0.0055
380 JAW DISORDER 30 0.0055
381 OROPHARYNGEAL PAIN 507 0.0055
382 EAR PAIN 106 0.0054
383 SARS-COV-2 TEST POSITIVE 72 0.0054
384 INTESTINAL ISCHAEMIA 30 0.0054
385 WOUND INFECTION 59 0.0054
386 TOOTH INFECTION 71 0.0054
387 INJECTION SITE SWELLING 412 0.0054
388 CARDIOMEGALY 66 0.0054
389 POST PROCEDURAL COMPLICATION 103 0.0054
390 GASTROINTESTINAL INFLAMMATION 42 0.0054
391 GAIT INABILITY 179 0.0054
392 SKIN LACERATION 58 0.0053
393 UPPER LIMB FRACTURE 106 0.0053
394 INJECTION SITE WARMTH 109 0.0053
395 GRAFT VERSUS HOST DISEASE 38 0.0053
396 ABDOMINAL DISCOMFORT 881 0.0052
397 BLOOD CALCIUM INCREASED 46 0.0052
398 ANEURYSM 26 0.0052
399 SKIN PLAQUE 44 0.0052
400 FLUID INTAKE REDUCED 26 0.0052
401 VEIN DISORDER 26 0.0052
402 LETHARGY 298 0.0052
403 EMPHYSEMA 52 0.0051
404 NASAL CONGESTION 302 0.0051
405 CONSTIPATION 1120 0.0051
406 HYPOVOLAEMIA 30 0.0051
407 BLOOD POTASSIUM INCREASED 83 0.0051
408 POLLAKIURIA 213 0.0051
409 SKIN DISCOLOURATION 234 0.0051
410 SKIN MASS 34 0.0051
411 ILEUS 63 0.0051
412 DECUBITUS ULCER 41 0.0050
413 URINARY INCONTINENCE 149 0.0050
414 HYPOTHYROIDISM 160 0.0050
415 PERIORBITAL OEDEMA 26 0.0050
416 PAIN IN EXTREMITY 1475 0.0050
417 COUGH 1402 0.0050
418 HYPERSOMNIA 143 0.0050
419 GAMMA-GLUTAMYLTRANSFERASE INCREASED 110 0.0050
420 OEDEMA 269 0.0050
421 LYMPHADENOPATHY 175 0.0049
422 HAND FRACTURE 35 0.0049
423 RENAL DISORDER 230 0.0049
424 HEPATIC ENCEPHALOPATHY 46 0.0049
425 BLOOD PRESSURE ABNORMAL 98 0.0049
426 CHILLS 576 0.0049
427 DISEASE PROGRESSION 581 0.0049
428 INTERNAL HAEMORRHAGE 56 0.0049
429 PROSTATIC DISORDER 27 0.0049
430 MUSCLE ATROPHY 62 0.0049
431 NECK PAIN 273 0.0049
432 DEATH 4192 0.0049
433 SPINAL DISORDER 46 0.0049
434 ARTHRITIS 382 0.0049
435 COMPRESSION FRACTURE 26 0.0048
436 VISUAL FIELD DEFECT 35 0.0048
437 HAEMATOCHEZIA 266 0.0048
438 EAR INFECTION 128 0.0048
439 GASTROINTESTINAL INFECTION 43 0.0048
440 GASTROENTERITIS 70 0.0048
441 GLYCOSYLATED HAEMOGLOBIN INCREASED 121 0.0048
442 SECRETION DISCHARGE 60 0.0048
443 NORMAL NEWBORN 26 0.0048
444 HEPATIC STEATOSIS 89 0.0048
445 HYPERHIDROSIS 614 0.0048
446 COLD SWEAT 84 0.0048
447 BLOOD GLUCOSE INCREASED 893 0.0047
448 BACTERIAL INFECTION 88 0.0047
449 ERUCTATION 91 0.0047
450 PRODUCT PHYSICAL CONSISTENCY ISSUE 26 0.0047
451 INJECTION SITE INJURY 26 0.0047
452 WEIGHT FLUCTUATION 49 0.0047
453 PHARYNGITIS 58 0.0047
454 EYE MOVEMENT DISORDER 32 0.0047
455 CATARACT 276 0.0046
456 CRYING 168 0.0046
457 INTERVERTEBRAL DISC PROTRUSION 101 0.0046
458 FEELING HOT 283 0.0046
459 PYELONEPHRITIS 40 0.0046
460 NEOPLASM MALIGNANT 308 0.0046
461 GENERALISED OEDEMA 57 0.0046
462 WRIST FRACTURE 55 0.0046
463 URINARY TRACT INFECTION 779 0.0046
464 SWELLING 427 0.0046
465 FATIGUE 3551 0.0046
466 HEPATIC FAILURE 137 0.0045
467 PROCEDURAL PAIN 126 0.0045
468 GASTROINTESTINAL CARCINOMA 41 0.0045
469 LIVER DISORDER 199 0.0045
470 NEURALGIA 109 0.0045
471 FACIAL PAIN 40 0.0045
472 FULL BLOOD COUNT DECREASED 90 0.0045
473 INJECTION SITE VESICLES 27 0.0045
474 DYSPNOEA EXERTIONAL 168 0.0045
475 SKIN LESION 122 0.0044
476 TONGUE DISORDER 32 0.0044
477 PRODUCT USE IN UNAPPROVED INDICATION 1094 0.0044
478 HYPOACUSIS 190 0.0044
479 VOMITING 2060 0.0044
480 FOOT FRACTURE 83 0.0044
481 GASTROENTERITIS VIRAL 79 0.0044
482 HYPOALBUMINAEMIA 34 0.0044
483 EPISTAXIS 326 0.0044
484 PRODUCT ADMINISTRATION ERROR 88 0.0043
485 SINUS BRADYCARDIA 42 0.0043
486 CHROMATURIA 98 0.0043
487 INFLAMMATION 223 0.0043
488 FEELING ABNORMAL 1034 0.0043
489 ORTHOSTATIC HYPOTENSION 75 0.0043
490 SWELLING OF EYELID 27 0.0043
491 ILLNESS 443 0.0043
492 SENSATION OF FOREIGN BODY 36 0.0043
493 PHOTOPSIA 27 0.0043
494 BLOOD BILIRUBIN INCREASED 115 0.0043
495 ESCHERICHIA INFECTION 35 0.0043
496 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 233 0.0042
497 PAIN 2599 0.0042
498 NERVE COMPRESSION 39 0.0042
499 LOCALISED INFECTION 102 0.0042
500 BLOOD ALKALINE PHOSPHATASE INCREASED 104 0.0042
501 PULMONARY CONGESTION 55 0.0042
502 LOSS OF CONSCIOUSNESS 534 0.0042
503 BLOOD ALBUMIN DECREASED 33 0.0042
504 APHONIA 58 0.0042
505 JOINT SWELLING 501 0.0041
506 POOR QUALITY SLEEP 89 0.0041
507 TENDONITIS 64 0.0041
508 DIZZINESS 2061 0.0041
509 APHTHOUS ULCER 32 0.0041
510 PLEURAL EFFUSION 251 0.0041
511 BLOOD DISORDER 33 0.0041
512 DIVERTICULITIS 114 0.0041
513 EMBOLISM 34 0.0041
514 ERYTHEMA 838 0.0041
515 HYPERTENSION 859 0.0041
516 LYMPHOEDEMA 28 0.0040
517 PYREXIA 1401 0.0040
518 BRONCHITIS 299 0.0040
519 THIRST 72 0.0040
520 MICTURITION URGENCY 46 0.0040
521 LUNG DISORDER 197 0.0040
522 BLOOD TRIGLYCERIDES INCREASED 71 0.0040
523 FEAR 108 0.0040
524 OVARIAN CANCER 37 0.0040
525 EXTRASYSTOLES 28 0.0040
526 RENAL IMPAIRMENT 336 0.0040
527 HEPATIC CANCER 96 0.0040
528 ARTHRALGIA 1657 0.0040
529 UPPER GASTROINTESTINAL HAEMORRHAGE 67 0.0040
530 SENSORY LOSS 32 0.0040
531 SPEECH DISORDER 208 0.0040
532 MOOD ALTERED 108 0.0040
533 NERVE INJURY 44 0.0040
534 METASTASES TO CENTRAL NERVOUS SYSTEM 51 0.0040
535 BLOOD TESTOSTERONE DECREASED 27 0.0039
536 HYPOTENSION 788 0.0039
537 FEAR OF INJECTION 28 0.0039
538 BLOOD THYROID STIMULATING HORMONE INCREASED 36 0.0039
539 COAGULOPATHY 65 0.0039
540 DYSPHONIA 228 0.0039
541 CHEST PAIN 722 0.0039
542 ROTATOR CUFF SYNDROME 50 0.0039
543 APNOEA 30 0.0038
544 PLATELET COUNT DECREASED 409 0.0038
545 PULMONARY HAEMORRHAGE 30 0.0038
546 HYPERCHOLESTEROLAEMIA 37 0.0038
547 HAEMORRHAGE 400 0.0038
548 TOOTH FRACTURE 42 0.0038
549 ASPHYXIA 31 0.0038
550 GASTROINTESTINAL DISORDER 340 0.0038
551 INJECTION SITE HAEMATOMA 55 0.0038
552 HYPOPHOSPHATAEMIA 28 0.0038
553 NAUSEA 2978 0.0038
554 ABSCESS 60 0.0038
555 ATRIAL FLUTTER 30 0.0038
556 CARDIAC FAILURE ACUTE 25 0.0037
557 HOSPICE CARE 37 0.0037
558 GLAUCOMA 72 0.0037
559 DIABETES MELLITUS INADEQUATE CONTROL 66 0.0037
560 VIRAL INFECTION 124 0.0037
561 PELVIC FRACTURE 29 0.0037
562 ARRHYTHMIA 176 0.0037
563 INCREASED APPETITE 71 0.0037
564 PULMONARY OEDEMA 166 0.0037
565 SLEEP DISORDER 261 0.0037
566 SCRATCH 39 0.0037
567 CELLULITIS 186 0.0037
568 STOMATITIS 223 0.0037
569 HYPOPHAGIA 94 0.0037
570 MEMORY IMPAIRMENT 503 0.0037
571 HYPERAESTHESIA 30 0.0036
572 PROCEDURAL COMPLICATION 28 0.0036
573 THERAPY NON-RESPONDER 164 0.0036
574 MUSCLE SPASMS 668 0.0036
575 ANGINA PECTORIS 104 0.0036
576 LUNG INFILTRATION 32 0.0036
577 HERPES ZOSTER 207 0.0036
578 HYPOCALCAEMIA 68 0.0036
579 HAEMATEMESIS 91 0.0036
580 CHOKING 70 0.0036
581 PRODUCT STORAGE ERROR 314 0.0036
582 BALANCE DISORDER 310 0.0036
583 RECTAL HAEMORRHAGE 154 0.0036
584 CARDIAC DISORDER 335 0.0036
585 IRON DEFICIENCY ANAEMIA 33 0.0036
586 EYE INFLAMMATION 34 0.0036
587 OSTEOPOROSIS 146 0.0035
588 MELAENA 78 0.0035
589 INJECTION SITE NODULE 39 0.0035
590 SPINAL FRACTURE 71 0.0035
591 GASTRITIS 93 0.0035
592 PRODUCT QUALITY ISSUE 480 0.0035
593 DIARRHOEA HAEMORRHAGIC 33 0.0035
594 HYPERTHYROIDISM 51 0.0035
595 MALIGNANT MELANOMA 47 0.0035
596 ATRIOVENTRICULAR BLOCK 27 0.0035
597 ANAEMIA 666 0.0035
598 COLON CANCER 52 0.0035
599 HYPOAESTHESIA 522 0.0035
600 ANXIETY 988 0.0035
601 ASPIRATION 38 0.0035
602 CARDIAC MURMUR 30 0.0035
603 BLOOD UREA INCREASED 58 0.0035
604 FLUID RETENTION 176 0.0035
605 LYMPHOCYTE COUNT DECREASED 61 0.0034
606 TYPE 2 DIABETES MELLITUS 116 0.0034
607 ORAL PAIN 77 0.0034
608 DEMENTIA 96 0.0034
609 LUNG NEOPLASM MALIGNANT 141 0.0034
610 VERTIGO 208 0.0034
611 HAEMATOMA 88 0.0034
612 GINGIVAL PAIN 27 0.0034
613 VITAMIN D DEFICIENCY 33 0.0034
614 DEVICE RELATED INFECTION 52 0.0034
615 MUSCULAR WEAKNESS 383 0.0034
616 BLOOD CHOLESTEROL INCREASED 157 0.0034
617 INJECTION SITE BRUISING 268 0.0034
618 MITRAL VALVE INCOMPETENCE 38 0.0034
619 TASTE DISORDER 68 0.0033
620 HEADACHE 2097 0.0033
621 MUSCLE DISORDER 27 0.0033
622 PELVIC PAIN 60 0.0033
623 PRODUCT USE ISSUE 619 0.0033
624 MOUTH ULCERATION 69 0.0033
625 DYSPEPSIA 322 0.0033
626 CONFUSIONAL STATE 527 0.0033
627 GLOMERULAR FILTRATION RATE DECREASED 40 0.0033
628 INTERVERTEBRAL DISC DEGENERATION 30 0.0032
629 INJECTION SITE EXTRAVASATION 40 0.0032
630 FOOD ALLERGY 25 0.0032
631 GASTROINTESTINAL HAEMORRHAGE 270 0.0032
632 CONCUSSION 25 0.0032
633 CARDIAC FAILURE 259 0.0032
634 MUSCLE TIGHTNESS 52 0.0032
635 SEPSIS 357 0.0032
636 PANCREATITIS 169 0.0032
637 ACCIDENT 38 0.0032
638 SWELLING FACE 207 0.0032
639 COLITIS 120 0.0032
640 THROMBOSIS 254 0.0032
641 LUNG INFECTION 49 0.0032
642 RETCHING 67 0.0031
643 PNEUMONIA 1017 0.0031
644 HEPATIC CIRRHOSIS 59 0.0031
645 HAND DEFORMITY 41 0.0031
646 CHEST DISCOMFORT 317 0.0031
647 BLINDNESS 126 0.0031
648 BRAIN INJURY 31 0.0031
649 HYPOMAGNESAEMIA 43 0.0031
650 URINARY RETENTION 103 0.0031
651 APATHY 45 0.0031
652 PRODUCT AVAILABILITY ISSUE 70 0.0031
653 PARALYSIS 44 0.0031
654 TACHYCARDIA 273 0.0031
655 CLOSTRIDIUM DIFFICILE INFECTION 67 0.0031
656 MOBILITY DECREASED 218 0.0030
657 DRUG INTOLERANCE 293 0.0030
658 PALPITATIONS 355 0.0030
659 PERICARDIAL EFFUSION 70 0.0030
660 INCONTINENCE 32 0.0030
661 FISTULA 34 0.0030
662 ANURIA 26 0.0030
663 INFLUENZA LIKE ILLNESS 248 0.0030
664 PANCREATIC CARCINOMA 87 0.0030
665 ROAD TRAFFIC ACCIDENT 126 0.0030
666 MYALGIA 510 0.0030
667 BURNING SENSATION 210 0.0030
668 INCORRECT DOSE ADMINISTERED 683 0.0030
669 EYE DISORDER 98 0.0030
670 DYSPNOEA 1686 0.0030
671 HAIR COLOUR CHANGES 37 0.0030
672 BLOOD CREATININE INCREASED 194 0.0030
673 WHITE BLOOD CELL COUNT INCREASED 113 0.0029
674 WHEEZING 174 0.0029
675 VISUAL IMPAIRMENT 363 0.0029
676 CARPAL TUNNEL SYNDROME 41 0.0029
677 INFECTION 420 0.0029
678 DISORIENTATION 113 0.0028
679 ANKLE FRACTURE 44 0.0028
680 WEIGHT INCREASED 636 0.0028
681 EYELID OEDEMA 33 0.0028
682 JOINT DISLOCATION 30 0.0028
683 POST PROCEDURAL HAEMORRHAGE 33 0.0028
684 HYPERCALCAEMIA 35 0.0028
685 VASCULITIS 33 0.0028
686 AMNESIA 184 0.0028
687 CIRCULATORY COLLAPSE 48 0.0028
688 HYPOKALAEMIA 130 0.0028
689 HUNGER 39 0.0028
690 DELIRIUM 97 0.0028
691 MULTIPLE ORGAN DYSFUNCTION SYNDROME 79 0.0028
692 GASTRIC HAEMORRHAGE 32 0.0028
693 PLATELET COUNT INCREASED 36 0.0028
694 IMMUNODEFICIENCY 41 0.0027
695 HEPATIC CYTOLYSIS 35 0.0027
696 RENAL FAILURE 364 0.0027
697 PULMONARY HYPERTENSION 57 0.0027
698 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
699 CANDIDA INFECTION 46 0.0027
700 TINNITUS 125 0.0027
701 SNEEZING 61 0.0027
702 DEAFNESS 71 0.0027
703 INCORRECT ROUTE OF DRUG ADMINISTRATION 97 0.0027
704 BACK DISORDER 44 0.0027
705 LIVER FUNCTION TEST INCREASED 58 0.0027
706 PHARYNGITIS STREPTOCOCCAL 29 0.0027
707 ACNE 203 0.0027
708 PANCREATITIS ACUTE 60 0.0027
709 ALOPECIA 523 0.0027
710 EMOTIONAL DISORDER 82 0.0027
711 MOTOR DYSFUNCTION 27 0.0026
712 PAIN IN JAW 75 0.0026
713 CARDIOMYOPATHY 39 0.0026
714 GINGIVAL BLEEDING 36 0.0026
715 UNRESPONSIVE TO STIMULI 68 0.0026
716 HIATUS HERNIA 34 0.0026
717 SKIN CANCER 56 0.0026
718 SEPTIC SHOCK 113 0.0026
719 MACULAR DEGENERATION 31 0.0026
720 INJECTION SITE REACTION 178 0.0026
721 PNEUMOTHORAX 41 0.0026
722 RESTLESS LEGS SYNDROME 47 0.0026
723 TOXIC SKIN ERUPTION 26 0.0026
724 THERAPEUTIC RESPONSE DECREASED 156 0.0026
725 EYE INFECTION 29 0.0026
726 ORAL HERPES 50 0.0026
727 COMA 121 0.0025
728 TOOTHACHE 46 0.0025
729 INSOMNIA 675 0.0025
730 DENTAL CARIES 28 0.0025
731 MENTAL DISORDER 110 0.0025
732 DYSARTHRIA 95 0.0025
733 HYPOAESTHESIA ORAL 38 0.0025
734 EYE SWELLING 93 0.0025
735 RASH PAPULAR 56 0.0025
736 PNEUMONITIS 68 0.0025
737 SKIN INFECTION 28 0.0025
738 TRANSIENT ISCHAEMIC ATTACK 84 0.0025
739 DISSEMINATED INTRAVASCULAR COAGULATION 35 0.0025
740 MUSCULOSKELETAL STIFFNESS 217 0.0025
741 SEASONAL ALLERGY 35 0.0025
742 HEPATIC ENZYME INCREASED 168 0.0025
743 CHOLECYSTECTOMY 28 0.0024
744 ASPARTATE AMINOTRANSFERASE INCREASED 130 0.0024
745 ATRIAL FIBRILLATION 238 0.0024
746 SINUS CONGESTION 33 0.0024
747 FACE OEDEMA 41 0.0024
748 PROTEINURIA 46 0.0024
749 SKIN DISORDER 80 0.0024
750 PROSTATIC SPECIFIC ANTIGEN INCREASED 33 0.0024
751 C-REACTIVE PROTEIN INCREASED 87 0.0024
752 SPLENOMEGALY 28 0.0024
753 QUALITY OF LIFE DECREASED 32 0.0024
754 DERMATITIS ALLERGIC 30 0.0024
755 NO THERAPEUTIC RESPONSE 29 0.0024
756 OSTEOMYELITIS 43 0.0024
757 HAEMOPTYSIS 66 0.0024
758 VENTRICULAR TACHYCARDIA 39 0.0024
759 SKIN ULCER 61 0.0024
760 BACTERAEMIA 28 0.0024
761 TREMOR 391 0.0024
762 CEREBROVASCULAR ACCIDENT 397 0.0023
763 GASTROOESOPHAGEAL REFLUX DISEASE 188 0.0023
764 LYMPHOMA 36 0.0023
765 HYPOXIA 82 0.0023
766 INCORRECT DOSE ADMINISTERED BY DEVICE 61 0.0023
767 PARAESTHESIA 365 0.0023
768 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 54 0.0023
769 SOMNOLENCE 465 0.0023
770 BASAL CELL CARCINOMA 36 0.0023
771 ORAL DISCOMFORT 32 0.0023
772 DEPRESSION 523 0.0023
773 LACRIMATION INCREASED 69 0.0023
774 LIVER FUNCTION TEST ABNORMAL 66 0.0023
775 PRESYNCOPE 55 0.0023
776 FEMUR FRACTURE 70 0.0023
777 MULTI-ORGAN FAILURE 39 0.0023
778 DYSPHAGIA 214 0.0023
779 PRODUCT DISPENSING ERROR 49 0.0022
780 CHOLESTASIS 43 0.0022
781 ABASIA 55 0.0022
782 ADRENAL INSUFFICIENCY 27 0.0022
783 MUCOSAL INFLAMMATION 58 0.0022
784 JOINT STIFFNESS 58 0.0022
785 INTERNATIONAL NORMALISED RATIO INCREASED 63 0.0022
786 FLUID OVERLOAD 32 0.0022
787 PULMONARY EMBOLISM 208 0.0022
788 EJECTION FRACTION DECREASED 34 0.0022
789 LOWER LIMB FRACTURE 42 0.0022
790 APHASIA 66 0.0022
791 HYPERKALAEMIA 76 0.0022
792 UPPER RESPIRATORY TRACT INFECTION 100 0.0022
793 HAEMATURIA 74 0.0022
794 RESPIRATORY DISORDER 64 0.0021
795 FIBROMYALGIA 52 0.0021
796 SINUSITIS 216 0.0021
797 CYANOSIS 33 0.0021
798 COVID-19 366 0.0021
799 BLISTER 117 0.0021
800 ULCER 33 0.0021
801 ANGER 70 0.0021
802 TOOTH DISORDER 46 0.0021
803 INJECTION SITE ERYTHEMA 254 0.0020
804 PRODUCT PHYSICAL ISSUE 41 0.0020
805 ALTERED STATE OF CONSCIOUSNESS 44 0.0020
806 DRUG RESISTANCE 52 0.0020
807 DRY MOUTH 164 0.0020
808 CARDIAC ARREST 166 0.0020
809 GASTRIC DISORDER 69 0.0020
810 COORDINATION ABNORMAL 28 0.0020
811 MYELODYSPLASTIC SYNDROME 29 0.0020
812 AGEUSIA 50 0.0020
813 ENCEPHALOPATHY 49 0.0020
814 IMPAIRED GASTRIC EMPTYING 27 0.0020
815 ORAL CANDIDIASIS 26 0.0020
816 OFF LABEL USE 1727 0.0020
817 OXYGEN SATURATION DECREASED 110 0.0020
818 GASTRIC ULCER 37 0.0019
819 DRY SKIN 259 0.0019
820 THROMBOCYTOPENIA 214 0.0019
821 OSTEOPENIA 29 0.0019
822 APPLICATION SITE PAIN 42 0.0019
823 HEPATIC FUNCTION ABNORMAL 71 0.0019
824 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
825 WHITE BLOOD CELL COUNT DECREASED 204 0.0019
826 THINKING ABNORMAL 35 0.0019
827 SENSORY DISTURBANCE 30 0.0019
828 CYTOMEGALOVIRUS INFECTION 31 0.0019
829 LABORATORY TEST ABNORMAL 55 0.0019
830 THERAPY PARTIAL RESPONDER 29 0.0019
831 SEIZURE 213 0.0018
832 SINUS TACHYCARDIA 26 0.0018
833 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 371 0.0018
834 DYSGEUSIA 136 0.0018
835 THROAT IRRITATION 82 0.0018
836 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 94 0.0018
837 FRACTURE 34 0.0018
838 MIGRAINE 171 0.0018
839 PRODUCT PRESCRIBING ISSUE 39 0.0018
840 GLOSSODYNIA 40 0.0018
841 PERITONITIS 37 0.0018
842 SHOCK 41 0.0018
843 PRURITUS 682 0.0018
844 BLINDNESS UNILATERAL 25 0.0018
845 RASH PRURITIC 96 0.0018
846 ARTHROPATHY 98 0.0018
847 AGITATION 128 0.0017
848 PANCYTOPENIA 97 0.0017
849 RASH ERYTHEMATOUS 82 0.0017
850 BLOOD COUNT ABNORMAL 26 0.0017
851 LIP SWELLING 57 0.0017
852 EPILEPSY 52 0.0017
853 RESPIRATORY FAILURE 124 0.0017
854 COGNITIVE DISORDER 79 0.0017
855 INJURY ASSOCIATED WITH DEVICE 34 0.0017
856 ILL-DEFINED DISORDER 101 0.0017
857 PRODUCT USE COMPLAINT 26 0.0016
858 VISION BLURRED 226 0.0016
859 PNEUMONIA ASPIRATION 41 0.0016
860 ELECTROCARDIOGRAM QT PROLONGED 59 0.0016
861 PRODUCT DOSE OMISSION ISSUE 482 0.0016
862 RESPIRATORY ARREST 45 0.0016
863 DISEASE RECURRENCE 77 0.0016
864 HEPATITIS 41 0.0016
865 METABOLIC ACIDOSIS 51 0.0016
866 IRRITABLE BOWEL SYNDROME 34 0.0016
867 EXPIRED PRODUCT ADMINISTERED 52 0.0016
868 DRUG INEFFECTIVE 2045 0.0016
869 HEMIPARESIS 26 0.0015
870 RESTLESSNESS 56 0.0015
871 HEPATOTOXICITY 34 0.0015
872 RESPIRATORY DISTRESS 42 0.0015
873 FEELING JITTERY 29 0.0015
874 OCULAR HYPERAEMIA 72 0.0015
875 STAPHYLOCOCCAL INFECTION 50 0.0015
876 PANIC ATTACK 55 0.0015
877 EYE PAIN 85 0.0015
878 DIPLOPIA 39 0.0015
879 ACUTE KIDNEY INJURY 229 0.0015
880 CEREBRAL HAEMORRHAGE 53 0.0015
881 BONE MARROW FAILURE 30 0.0015
882 SWOLLEN TONGUE 46 0.0015
883 TREATMENT FAILURE 121 0.0015
884 CARDIOVASCULAR DISORDER 37 0.0015
885 CONJUNCTIVITIS 27 0.0015
886 PRODUCT DOSE OMISSION 95 0.0015
887 RASH 634 0.0015
888 HYPONATRAEMIA 81 0.0014
889 PHOTOPHOBIA 27 0.0014
890 LIVER INJURY 35 0.0014
891 ALANINE AMINOTRANSFERASE INCREASED 87 0.0014
892 VISUAL ACUITY REDUCED 47 0.0014
893 SINUS DISORDER 28 0.0014
894 FUNGAL INFECTION 47 0.0014
895 HYPERSENSITIVITY 261 0.0014
896 DYSKINESIA 57 0.0014
897 TOOTH LOSS 29 0.0014
898 MYOCARDIAL INFARCTION 243 0.0014
899 NEUROPATHY PERIPHERAL 132 0.0014
900 SKIN FISSURES 27 0.0014
901 NEUTROPHIL COUNT DECREASED 56 0.0014
902 RASH GENERALISED 35 0.0014
903 GASTRIC CANCER 34 0.0013
904 ACCIDENTAL EXPOSURE TO PRODUCT 135 0.0013
905 IMPAIRED HEALING 43 0.0013
906 BREAST CANCER 122 0.0013
907 DEEP VEIN THROMBOSIS 85 0.0013
908 CARDIAC FAILURE CONGESTIVE 105 0.0013
909 DRUG ADMINISTRATION ERROR 40 0.0013
910 PRODUCT PRESCRIBING ERROR 31 0.0013
911 URTICARIA 216 0.0013
912 FEBRILE NEUTROPENIA 85 0.0013
913 HOSPITALISATION 195 0.0013
914 INJURY 89 0.0013
915 RASH MACULO-PAPULAR 28 0.0013
916 CONDITION AGGRAVATED 377 0.0012
917 IRRITABILITY 74 0.0012
918 DEVICE LEAKAGE 52 0.0012
919 PREMATURE BABY 36 0.0012
920 DERMATITIS 25 0.0012
921 DISTURBANCE IN ATTENTION 63 0.0012
922 MENTAL IMPAIRMENT 28 0.0012
923 MENTAL STATUS CHANGES 32 0.0012
924 INCORRECT DRUG ADMINISTRATION DURATION 32 0.0011
925 DEPRESSED LEVEL OF CONSCIOUSNESS 45 0.0011
926 RENAL FAILURE ACUTE 48 0.0011
927 CARDIO-RESPIRATORY ARREST 47 0.0011
928 CEREBRAL INFARCTION 27 0.0011
929 MOOD SWINGS 35 0.0011
930 VAGINAL HAEMORRHAGE 47 0.0011
931 INTERSTITIAL LUNG DISEASE 51 0.0011
932 ECZEMA 55 0.0010
933 OSTEONECROSIS OF JAW 26 0.0010
934 RASH MACULAR 36 0.0010
935 AGGRESSION 51 0.0010
936 ANAPHYLACTIC REACTION 56 0.0010
937 LEUKOPENIA 50 0.0010
938 RESPIRATORY TRACT INFECTION 26 0.0010
939 THROAT TIGHTNESS 27 0.0010
940 BONE DENSITY DECREASED 31 0.0010
941 INJECTION SITE RASH 30 0.0010
942 DRUG INTERACTION 155 0.0010
943 SURGERY 57 0.0010
944 INJECTION SITE PRURITUS 65 0.0010
945 RHABDOMYOLYSIS 40 0.0010
946 CHRONIC KIDNEY DISEASE 72 0.0009
947 DEVICE MALFUNCTION 66 0.0009
948 MEDICATION ERROR 52 0.0009
949 NERVOUS SYSTEM DISORDER 29 0.0009
950 MYELOSUPPRESSION 33 0.0009
951 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 65 0.0009
952 NIGHTMARE 31 0.0009
953 SKIN EXFOLIATION 75 0.0009
954 ASTHMA 99 0.0009
955 SUICIDAL IDEATION 80 0.0009
956 SKIN IRRITATION 40 0.0009
957 MATERNAL EXPOSURE DURING PREGNANCY 77 0.0009
958 NEUTROPENIA 117 0.0009
959 DEVICE ISSUE 75 0.0008
960 ABNORMAL BEHAVIOUR 33 0.0008
961 CORONARY ARTERY DISEASE 25 0.0008
962 PLASMA CELL MYELOMA 32 0.0008
963 TREATMENT NONCOMPLIANCE 44 0.0008
964 TOXICITY TO VARIOUS AGENTS 134 0.0008
965 HALLUCINATION 58 0.0008
966 THERAPEUTIC RESPONSE UNEXPECTED 34 0.0008
967 EMOTIONAL DISTRESS 91 0.0008
968 ADVERSE DRUG REACTION 67 0.0007
969 PROSTATE CANCER 60 0.0007
970 DRY EYE 37 0.0007
971 EYE IRRITATION 42 0.0007
972 THERAPY CESSATION 37 0.0007
973 THERAPY INTERRUPTED 50 0.0007
974 RHEUMATOID ARTHRITIS 79 0.0007
975 PRODUCT SUBSTITUTION ISSUE 39 0.0007
976 FOETAL EXPOSURE DURING PREGNANCY 50 0.0006
977 DRUG EFFECT DECREASED 33 0.0006
978 RENAL CANCER 29 0.0006
979 SUICIDE ATTEMPT 35 0.0006
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 26 0.0006
981 BLADDER CANCER 31 0.0005
982 DEVICE DIFFICULT TO USE 33 0.0005
983 SKIN BURNING SENSATION 34 0.0005
984 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
985 NO ADVERSE EVENT 84 0.0005
986 ADVERSE EVENT 37 0.0004
987 PSORIASIS 51 0.0004
988 OVERDOSE 76 0.0004
989 INTENTIONAL PRODUCT MISUSE 29 0.0003
990 DRUG DOSE OMISSION 49 0.0003
991 DRUG DEPENDENCE 36 0.0002